Activate or download XIFAXAN Savings Card

With the XIFAXAN Savings Card, eligible patients* with commercial insurance may pay no more than $0 for their XIFAXAN prescription.
saving card

If for any reason you do not have a XIFAXAN Instant Savings Card, an eVoucher may also be available if you are deemed eligible at the pharmacy. eVoucher savings do not require any activation and are applied automatically for eligible patients at over 41,000 pharmacies with a XIFAXAN prescription and the eVoucher can be automatically applied at participating eVoucherRxTM pharmacies. Visit eVoucherRx.RelayHealth.com/storelookup to find a local participating store.

*Maximum benefits and other restrictions apply. Please see below for the program's full Eligibility Criteria, Terms and Conditions.

Do you want to download or activate a XIFAXAN Instant Savings Card?

I do not have a XIFAXAN Instant Savings Card and would like to download and activate one now.
I already have a XIFAXAN Instant Savings Card and would like to activate it now.

All personal information will be kept confidential and will not be shared with any third parties other than Salix Pharmaceuticals and its designated partners.

By clicking SUBMIT and activating a Xifaxan Instant Savings Card, I confirm that I have read and understood the Eligibility Criteria and Terms and Conditions contained above, and that the patient who will use the savings card meets all eligibility criteria and will comply with all terms and conditions of the program.

Eligibility Criteria, Terms and Conditions: This offer is only valid for patients with commercial insurance, including commercially-insured patients without coverage for Xifaxan. Patients without commercial insurance are not eligible. Commercially-insured patients with coverage for Xifaxan will receive savings to reduce their copay to as little as $0. Commercially-insured patients without coverage for Xifaxan will receive savings off of retail price to reduce the out-of-pocket cost to as little as $50. Maximum benefits apply. For information about the maximum benefits please visit www.xifaxan.com and/or call the helpline 1-866-XIFAXAN (option 1). Patient is responsible for all additional costs and expenses after application of the maximum benefits. You must activate this coupon before using it by visiting Xifaxan.com, calling 1-866-XIFAXAN, or texting PAYZERO to 24109. Message and data rates may apply. The full terms can be viewed at https://copaysavingsprogram.com/110/Xifaxan/sms-terms. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is only good in the USA at participating retail pharmacies. This offer cannot be redeemed at other locations, including government-subsidized clinics or facilities. This offer is not valid where otherwise prohibited, taxed, or otherwise restricted. Patient is responsible for reporting receipt of co-pay assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. This offer cannot be combined with other offers. This card has no cash value. No other purchase is necessary. This offer is nontransferable. No substitutions are permitted. This card is not health insurance. You understand and agree to comply with the terms and conditions of this offer as set forth above. Salix Pharmaceuticals reserves the right to rescind, revoke, or amend this offer at any time without notice. This offer expires on December 31, 2019.

INDICATIONS

XIFAXAN®(refaximin) 550 mg tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults and for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.
  • If you take antibiotics, like XIFAXAN , there is a chance you could experience diarrhea caused by an overgrowth of bacteria ( C. difficile). This can cause symptoms of ranging is severity from mild dirrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
  • Talk to your healthcare provider before taking XIFAXAN if you have severe hepatic(liver), impairment as this may cause increased, effects of the medicine.
  • Tell your healthcare provider if you are taking drugs called P-glycoprotein inhibitors(such as cyclosporine) because using these drugs with XIFAXAN may lead to an increases in the amount of XIFAXAN absorbed by your body.
  • If you are pregnant, planning to become pregnant, or nursing, talk to your healthcare provider before taking XIFAXAN because XIFAXAN may cause harm to an unborn baby or nursing infant.
  • In clinical studies, the most common side effects of XIFAXAN were:
    • HE: peripheral edema(swelling usually in the ankles or lower limbs), nausea (feeling sick to your stomach), dizziness, fatigue (feeling tired), and ascites (a buildup of fluid in the abdomen).
    • IBS-D: Nausea(feeling sick to your stomach) and an increase in liver enzymes.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:
Salix Product Information Call center
Phone: 1-800-321-4576
Fax: 1-510-595-8183
Email: salixmc@dlss.com

Please click here for full Prescribing Information.

The health information contained herein is provided for educational purposes only and is not intended to replace discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

INDICATIONS

IMPORTANT SAFETY INFORMATION

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria ( C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
{"crx-wl-channel":"web","crx-wl-survey-description":"Agreement Certification","crx-wl-survey-name":"Valeant- Xifaxan Survey v1.0.0","groupNumber":"AC68036002","client":"valeant","brand":"xifaxan","view":"home"}